These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25613108)

  • 1. Role of BNP and echo measurement for pulmonary hypertension recognition in patients with interstitial lung disease: An algorithm application model.
    Ruocco G; Cekorja B; Rottoli P; Refini RM; Pellegrini M; Di Tommaso C; Del Castillo G; Franci B; Nuti R; Palazzuoli A
    Respir Med; 2015 Mar; 109(3):406-15. PubMed ID: 25613108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two simple echo-Doppler measurements can accurately identify pulmonary hypertension in the large majority of patients with chronic heart failure.
    Lanzarini L; Fontana A; Campana C; Klersy C
    J Heart Lung Transplant; 2005 Jun; 24(6):745-54. PubMed ID: 15949736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional Echocardiography of Right Ventricular Function Correlates with Severity of Pediatric Pulmonary Hypertension.
    Jone PN; Patel SS; Cassidy C; Ivy DD
    Congenit Heart Dis; 2016 Dec; 11(6):562-569. PubMed ID: 26899626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelin-1 and brain natriuretic peptide in the development of pulmonary hypertension in interstitial lung diseases].
    Fomin VV; Popova EN; Kuznetsova AV; Popova IA; Churganova LIu; Osipenko VI; Mukhin NA
    Ter Arkh; 2009; 81(12):58-63. PubMed ID: 20481052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Right atrium contractility and right ventricular diastolic function assessed by pulsed tissue Doppler imaging can predict brain natriuretic peptide in adults with acquired pulmonary hypertension.
    Shiina Y; Funabashi N; Lee K; Daimon M; Sekine T; Kawakubo M; Takahashi M; Yajima R; Tanabe N; Kuriyama T; Komuro I
    Int J Cardiol; 2009 Jun; 135(1):53-9. PubMed ID: 18793807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of contemporary echo and BNP assessment in patients with acute heart failure during early hospitalization.
    Palazzuoli A; Beltrami M; Ruocco G; Franci B; Campagna MS; Nuti R
    Eur J Intern Med; 2016 May; 30():43-48. PubMed ID: 26718066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
    Amsallem M; Boulate D; Kooreman Z; Zamanian RT; Fadel G; Schnittger I; Fadel E; McConnell MV; Dhillon G; Mercier O; Haddad F
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):825-835. PubMed ID: 28120156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of right ventricular Tei-index for assessing disease severity and determining response to treatment in patients with pulmonary arterial hypertension.
    Ogihara Y; Yamada N; Dohi K; Matsuda A; Tsuji A; Ota S; Ishikura K; Nakamura M; Ito M
    J Cardiol; 2014 Feb; 63(2):149-53. PubMed ID: 24012334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated nocturnal desaturation index predicts mortality in interstitial lung disease.
    Corte TJ; Wort SJ; Talbot S; Macdonald PM; Hansel DM; Polkey M; Renzoni E; Maher TM; Nicholson AG; Wells AU
    Sarcoidosis Vasc Diffuse Lung Dis; 2012 Mar; 29(1):41-50. PubMed ID: 23311122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis.
    Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C
    J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary hypertension in advanced lung diseases: Echocardiography as an important part of patient evaluation for lung transplantation.
    Nowak J; Hudzik B; Jastrzȩbski D; Niedziela JT; Rozentryt P; Wojarski J; Ochman M; Karolak W; Żegleń S; Gierlotka M; Gąsior M
    Clin Respir J; 2018 Mar; 12(3):930-938. PubMed ID: 28052583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive capacity of the brain natriuretic peptide in the screening of heart failure in a high altitude population.
    Calderón-Gerstein W; Bruno-Huamán A; Damián-Mucha M; Huayllani-Flores L
    Respir Physiol Neurobiol; 2021 Jul; 289():103654. PubMed ID: 33746081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Estimation of plasmic concentration of the brain natriuretic peptide in interstitial pulmonary diseases with pulmonary hypertension: clinical role].
    Mukhin NA; Fomin VV; Popova EN; Kuznetsova AV; Popova IA; Churganova LIu; Osipenko VI
    Ter Arkh; 2009; 81(3):47-51. PubMed ID: 19459423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
    Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restrictive filling pattern predicts pulmonary hypertension and is associated with increased BNP levels and impaired exercise capacity in patients with heart failure.
    Straburzyńska-Migaj E; Szyszka A; Trojnarska O; Cieśliński A
    Kardiol Pol; 2007 Sep; 65(9):1049-55; discussion 1056-7. PubMed ID: 17975752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary vascular resistance estimated by Doppler echocardiography predicts mortality in patients with interstitial lung disease.
    Yasui K; Yuda S; Abe K; Muranaka A; Otsuka M; Ohnishi H; Hashimoto A; Takahashi H; Tsuchihashi K; Takahashi H; Takahashi S; Miura T
    J Cardiol; 2016 Oct; 68(4):300-7. PubMed ID: 27032318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of Brain Natriuretic Peptide for Diagnosing Pulmonary Hypertension in Severe Bronchopulmonary Dysplasia.
    Avitabile CM; Ansems S; Wang Y; Fraga MV; Kirpalani HM; Zhang H; Mercer-Rosa L; Jensen EA
    Neonatology; 2019; 116(2):147-153. PubMed ID: 31096210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension.
    Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P
    Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.